Search

Search Constraints

You searched for: Author/Creator Nakamura, Keiichi

Search Results

1. Current status of first‐line treatment with pembrolizumab for non–small‐cell lung cancer with high PD‐L1 expression. Issue 6 (15th April 2022)

3. Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non–small cell lung cancer. (January 2022)

4. Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902). (June 2021)